Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
p-methyl-N-salicyloyl Tryptamine is a neuroprotective agent and derivative of N-salicyloyl tryptamine.1 It reduces LPS-induced nitric oxide (NO) production in C6 rat glioma cells and BV-2 mouse microglia (IC50s = 7.48 and 4.94 µM, respectively). It also reduces LPS-induced production of TNF-α and prostaglandin E2 (PGE2; Item No. 14010) and increases production of IL-10 in BV-2 microglia when used at a concentration of 40 µM. In vivo, p-methyl-N-salicyloyl tryptamine (25-100 mg/kg) decreases cortical and hippocampal amyloid-β (Aβ) plaque formation and neuronal pyroptosis, as well as improves spatial learning and memory, in a mouse model of Aβ-induced Alzheimer’s disease.2
WARNING This product is not for human or veterinary use.
1. Design, synthesis and bioactivity study of N-
2. N-